Dr. Vivien Burt, a specialist in bipolar disorder treatment and research, dives into the nuanced discussion of lithium use during pregnancy. She unpacks the potential risks, including cardiac malformations, drawing on recent studies comparing lithium with other mood stabilizers. The conversation balances these risks against the dangers of untreated bipolar disorder. Listeners gain insights into the dose-dependent nature of these risks and the importance of informed treatment choices for pregnant women.
Lithium use during pregnancy poses dose-dependent risks for cardiac anomalies, emphasizing the need for careful dosage management beyond 900 milligrams daily.
The stability of the mother's bipolar disorder is crucial, as untreated episodes can severely impact both maternal and fetal health, necessitating informed treatment decisions.
Deep dives
Risks Associated with Lithium Use During Pregnancy
Prenatal exposure to lithium increases the risk of cardiovascular anomalies, particularly right ventricular outflow defects, although this risk is dose-dependent and generally small. A significant study indicated that the absolute risk of cardiac malformations was approximately 2.41 cases per hundred exposures to lithium compared to 1.15 cases in unexposed individuals. Importantly, when lithium doses are kept below 900 milligrams per day, the associated risks are much lower, highlighting the importance of monitoring and potentially adjusting dosages in pregnant women. The findings suggest that while there are risks linked to lithium use, these must be carefully weighed against the stability of the mother's bipolar disorder and the risks of discontinuing the medication altogether.
Balancing Treatment Options and Risks
Deciding on the best treatment approach for pregnant women with bipolar disorder involves weighing the risks of lithium exposure against the consequences of not treating the disorder. The potential relapse of bipolar disorder during pregnancy can have severe repercussions for both mother and child, making it crucial to maintain medication adherence. Alternatives to lithium, such as lamotrigine or atypical antipsychotics, may be less effective and come with their own risks, which are limited in their studies regarding bipolar disorder. Thus, a thorough discussion between clinician and patient is essential to navigate treatment decisions and prioritize the health of both the mother and fetus.
In this episode, we explore the risks and benefits of using lithium during pregnancy for women with bipolar disorder. We discuss recent research on cardiac malformations and dose-dependent risks. Is the fear of lithium use in pregnancy justified by the latest evidence?
Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D.